The most important financial indicators for the company Ilmans Research Medicine Srl - Unique Identification Number 38078171:
sales in 2023 was
11.238
euro, registering a net profit of
-2.271
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
Ilmans Research Medicine Srl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
-
-
-
16.198
80.662
63.246
15.044
3.672
4.402
11.238
Total Income - EUR
-
-
-
16.198
80.662
63.804
15.837
4.198
4.872
11.493
Total Expenses - EUR
-
-
-
166
7.573
19.183
21.113
18.275
16.836
13.764
Gross Profit/Loss - EUR
-
-
-
16.032
73.089
44.621
-5.276
-14.077
-11.964
-2.271
Net Profit/Loss - EUR
-
-
-
15.546
70.669
43.015
-5.627
-14.188
-12.096
-2.271
Employees
-
-
-
0
0
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 156.1%, from 4.402 euro in the year 2022, to 11.238 euro in 2023.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ilmans Research Medicine Srl - CUI 38078171
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
5
3
34.134
23.299
12.971
3.718
0
Current Assets
-
-
-
16.233
82.496
46.340
32.191
27.266
17.454
8.949
Inventories
-
-
-
0
0
0
0
0
0
0
Receivables
-
-
-
0
5.752
3.456
527
371
373
1.228
Cash
-
-
-
16.233
76.744
42.884
31.664
26.895
17.081
7.722
Shareholders Funds
-
-
-
15.590
70.720
43.065
-5.577
-19.641
-31.798
-33.973
Social Capital
-
-
-
44
43
42
41
40
41
40
Debts
-
-
-
648
11.779
37.850
61.786
60.537
53.671
43.210
Income in Advance
-
-
-
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
8.949 euro in 2023 which includes Inventories of
0 euro, Receivables of
1.228 euro and cash availability of
7.722 euro.
The company's Equity was valued at
-33.973 euro, while total Liabilities amounted to
43.210 euro.
Equity decreased by -2.271 euro, from -31.798 euro in 2022, to -33.973 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ilmans Research Medicine Srl